Estatísticas para NT 2022.0003169 Esclerose tuberosa Everolimus, levatiracetan, lamotrigna - NATJUS TJMG

Total de visitas

views
NT 2022.0003169 Esclerose tuberosa Everolimus, levatiracetan, lamotrigna - NATJUS TJMG 47

Total visitas por mês

views
October 2025 1
November 2025 0
December 2025 0
January 2026 0
February 2026 0
March 2026 1
April 2026 1

Visitas Arquivos

views
NT 2022.0003169 Esclerose tuberosa Everolimus, levatiracetan, lamotrigna.pdf 60